Výsledky vyhledávání - Prithviraj, Prashanth
- Zobrazuji výsledky 1 - 13 z 13
-
1
-
2
-
3
-
4
-
5
-
6
Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma Autor Atkinson, Victoria, Khattak, Adnan, Haydon, Andrew, Eastgate, Melissa, Roy, Amitesh, Prithviraj, Prashanth, Mueller, Christian, Brignone, Chrystelle, Triebel, Frederic
Vydáno 2020Text -
7
Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma Autor Shrestha, Ritu, Prithviraj, Prashanth, Anaka, Matthew, Bridle, Kim R., Crawford, Darrell H. G., Dhungel, Bijay, Steel, Jason C., Jayachandran, Aparna
Vydáno 2018Text -
8
Aberrant pregnancy-associated plasma protein-A expression in breast cancers prognosticates clinical outcomes Autor Prithviraj, Prashanth, Anaka, Matthew, Thompson, Erik W., Sharma, Revati, Walkiewicz, Marzena, Tutuka, Candani S. A., Behren, Andreas, Kannourakis, George, Jayachandran, Aparna
Vydáno 2020Text -
9
Prognostic Role of Immune Checkpoint Regulators in Cholangiocarcinoma: A Pilot Study Autor Cao, Lu, Prithviraj, Prashanth, Shrestha, Ritu, Sharma, Revati, Anaka, Matthew, Bridle, Kim R., Kannourakis, George, Crawford, Darrell H.G., Jayachandran, Aparna
Vydáno 2021Text -
10
Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells Autor Jayachandran, Aparna, Lo, Pu-Han, Chueh, Anderly C., Prithviraj, Prashanth, Molania, Ramyar, Davalos-Salas, Mercedes, Anaka, Matthew, Walkiewicz, Marzena, Cebon, Jonathan, Behren, Andreas
Vydáno 2016Text -
11
Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma Autor Jayachandran, Aparna, Anaka, Matthew, Prithviraj, Prashanth, Hudson, Christopher, McKeown, Sonja J, Lo, Pu-Han, Vella, Laura J, Goding, Colin R, Cebon, Jonathan, Behren, Andreas
Vydáno 2014Text -
12
Identifying and targeting determinants of melanoma cellular invasion Autor Jayachandran, Aparna, Prithviraj, Prashanth, Lo, Pu-Han, Walkiewicz, Marzena, Anaka, Matthew, Woods, Briannyn L., Tan, BeeShin, Behren, Andreas, Cebon, Jonathan, McKeown, Sonja J.
Vydáno 2016Text -
13
Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'' Autor Bowyer, Samantha, Prithviraj, Prashanth, Lorigan, Paul, Larkin, James, McArthur, Grant, Atkinson, Victoria, Millward, Michael, Khou, Muoi, Diem, Stefan, Ramanujam, Sangeetha, Kong, Ben, Liniker, Elizabeth, Guminski, Alexander, Parente, Phillip, Andrews, Miles C, Parakh, Sagun, Cebon, Jonathan, Long, Georgina V, Carlino, Matteo S, Klein, Oliver
Vydáno 2017Text